Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi B Segal

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
American Journal of Hematology|August 29, 2009
Need for comparative effectiveness research to address clinical questions in hematologyJodi B Segal
Clinical Trials (London, England)|July 12, 2020
Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populationsJodi B Segal,
ACP Journal Club|May 5, 2004
D-dimer testing reduced the need for ultrasonographic imaging in outpatients with suspected deep venous thrombosisJodi B Segal
Journal of General Internal Medicine|June 1, 2012
Chapter 3: choosing the important outcomes for a systematic review of a medical testJodi B Segal
Annals of Internal Medicine|February 5, 2024
Reducing Low-Value Health CareJodi B Segal
Journal of General Internal Medicine|March 31, 2016
More Challenges in Measuring Care QualityJodi B Segal
JAMA Oncology|October 9, 2025
Limitations in Quantitative Harm-Benefit Assessment in Immuno-Oncology-ReplyJames Heyward, Jodi B Segal
American Journal of Epidemiology|November 2, 2019
Segal and Varadhan Respond to "Estimation With Claims-Based Frailty Indexes"Jodi B Segal, Ravi Varadhan
Journal of General Internal Medicine|January 16, 2010
What can the VA teach us about implementing proven advances into routine clinical practice?Jeff Whittle, Jodi B Segal
Archives of Internal Medicine|June 13, 2012
Thiazolidinediones and macular edema: comment on "Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes"Sonal Singh, Jodi B Segal
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
American Journal of Hematology|August 29, 2009
Need for comparative effectiveness research to address clinical questions in hematologyJodi B Segal
Clinical Trials (London, England)|July 12, 2020
Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populationsJodi B Segal,
ACP Journal Club|May 5, 2004
D-dimer testing reduced the need for ultrasonographic imaging in outpatients with suspected deep venous thrombosisJodi B Segal
Journal of General Internal Medicine|June 1, 2012
Chapter 3: choosing the important outcomes for a systematic review of a medical testJodi B Segal
Annals of Internal Medicine|February 5, 2024
Reducing Low-Value Health CareJodi B Segal
Journal of General Internal Medicine|March 31, 2016
More Challenges in Measuring Care QualityJodi B Segal
JAMA Oncology|October 9, 2025
Limitations in Quantitative Harm-Benefit Assessment in Immuno-Oncology-ReplyJames Heyward, Jodi B Segal
American Journal of Epidemiology|November 2, 2019
Segal and Varadhan Respond to "Estimation With Claims-Based Frailty Indexes"Jodi B Segal, Ravi Varadhan
Journal of General Internal Medicine|January 16, 2010
What can the VA teach us about implementing proven advances into routine clinical practice?Jeff Whittle, Jodi B Segal
Archives of Internal Medicine|June 13, 2012
Thiazolidinediones and macular edema: comment on "Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes"Sonal Singh, Jodi B Segal
Pageof 21